Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".
Zurich,Switzerland
More info
Innate Pharma and Novo Nordisk A/S sign licensing deal
November 14, 2003
| Download Area |
|---|
| PR in english |